Opportunity Information: Apply for HT942526PRCRPCTA
The FY26 Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) from the Department of the Army (USAMRAA) is a discretionary grant opportunity designed to move cancer research quickly into the clinic. The program is focused on the rapid implementation of clinical trials that could meaningfully improve how cancer is treated or managed, as long as the proposed work fits within at least one of the FY26 PRCRP Topic Areas. In practical terms, this award is meant for projects that are ready to test an intervention in people and have a clear potential to change clinical practice, patient outcomes, or standards of care if successful.
A defining requirement of this funding mechanism is that the application must include a clinical trial. The program allows a wide range of trial stages, from early, exploratory studies such as pilot trials, first-in-human work, or phase 0 efforts that generate key feasibility and biological effect data, all the way through larger, more definitive trials up to phase III that test efficacy in the intended patient population. The types of interventions supported are broad and can include new or repurposed pharmacologic agents (drugs or biologics), medical devices, clinical guidance or care pathways, and newer approaches or technologies that may improve diagnosis, treatment delivery, monitoring, or overall management of cancer.
The solicitation also places strong emphasis on regulatory readiness when it applies. If the proposed clinical trial requires an Investigational New Drug (IND) application, an Investigational Device Exemption (IDE), or an equivalent regulatory submission, that regulatory application must already be submitted to the appropriate agency by the CTA application submission deadline. Importantly, the submission needs to match the specific product (or device) and the specific cancer indication being tested in the proposed trial, signaling that applicants should be well beyond the concept stage and positioned to start the trial without long regulatory delays.
Another distinctive feature is the required inclusion of patient advocates as part of the application. This reflects an expectation that patient perspectives will be integrated into the design and conduct of the trial, such as ensuring the research questions are meaningful to patients, the protocol is feasible and considerate of participant burden, recruitment and retention plans are realistic, and outcomes include measures that matter to people living with cancer.
This award does not support animal studies. Any preclinical development, including animal efficacy or toxicology work needed to justify human testing, must be completed before the award start date. As a result, this mechanism is best suited to teams that have already generated the necessary preclinical or translational evidence and are ready to execute a human clinical trial promptly.
Key administrative details include the opportunity number HT942526PRCRPCTA and a closing date of October 5, 2026. The funding instrument is a grant under the science and technology/research and development category (CFDA 12.420). Eligibility is listed as unrestricted, and the program anticipates making about 10 awards. The award ceiling is not specified in the provided listing, so applicants would need to consult the full announcement or agency guidance for budget limits and any cost-related constraints.Apply for HT942526PRCRPCTA
- The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoW Peer Reviewed Cancer, Clinical Trial Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on 2026-05-06.
- Applicants must submit their applications by 2026-10-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 10 candidate(s).
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FY26 PRCRP Clinical Trial Award (CTA) - Frequently Asked Questions (FAQs)
1) What is the FY26 PRCRP Clinical Trial Award (CTA)?
The FY26 Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) is a discretionary grant opportunity from the Department of the Army (USAMRAA) intended to move promising cancer research quickly into the clinic. It supports the rapid implementation of clinical trials that could meaningfully improve how cancer is treated or managed, as long as the project fits within at least one FY26 PRCRP Topic Area.
2) Who is the funding agency for this opportunity?
The funding agency is the Department of the Army, administered through USAMRAA (U.S. Army Medical Research Acquisition Activity).
3) What is the opportunity number?
The opportunity number is HT942526PRCRPCTA.
4) What is the application closing date?
The closing date listed is October 5, 2026.
5) What type of funding instrument is this?
This opportunity uses a grant funding instrument under the science and technology / research and development category.
6) What is the CFDA number associated with this program?
The CFDA number provided is 12.420.
7) What kinds of projects are a good fit for this award?
This award is designed for projects that are ready to test an intervention in people (i.e., in a clinical trial) and that have clear potential to change clinical practice, patient outcomes, or standards of care if successful. The proposed work must align with at least one FY26 PRCRP Topic Area.
8) Is a clinical trial required to apply?
Yes. A defining requirement is that the application must include a clinical trial.
9) What phases or stages of clinical trials does the CTA support?
The CTA supports a wide range of trial stages, from early exploratory studies (such as pilot trials, first-in-human work, or phase 0 efforts) through larger, more definitive trials up to phase III that test efficacy in the intended patient population.
10) What types of interventions can be tested in the supported clinical trials?
Supported interventions are broad and can include new or repurposed pharmacologic agents (drugs or biologics), medical devices, clinical guidance or care pathways, and newer approaches or technologies that may improve diagnosis, treatment delivery, monitoring, or overall management of cancer.
11) Does the proposed project have to match specific PRCRP Topic Areas?
Yes. The program requires that the proposed work fits within at least one of the FY26 PRCRP Topic Areas.
12) What does the program mean by an emphasis on "rapid implementation"?
Based on the description, the intent is to fund clinical trials that can start without long delays and are positioned to produce clinically meaningful evidence, rather than projects still in concept development or extended preclinical build-out.
13) Are regulatory submissions (IND/IDE) required before applying?
If the proposed clinical trial requires an Investigational New Drug (IND) application, an Investigational Device Exemption (IDE), or an equivalent regulatory submission, then that regulatory application must already be submitted to the appropriate agency by the CTA application submission deadline.
14) Does the IND/IDE submission need to match the proposed trial exactly?
Yes. The submission needs to match the specific product (or device) and the specific cancer indication being tested in the proposed trial.
15) What does the regulatory readiness requirement imply for applicants?
It implies applicants should be well beyond the concept stage and positioned to start the trial without long regulatory delays, because the relevant IND/IDE (or equivalent) must already be submitted by the application deadline when required.
16) Are patient advocates required for this award?
Yes. The solicitation requires inclusion of patient advocates as part of the application.
17) Why are patient advocates required, based on the opportunity description?
The requirement reflects an expectation that patient perspectives will be integrated into trial design and conduct. Examples mentioned include making sure the research questions are meaningful to patients, the protocol is feasible and considerate of participant burden, recruitment and retention plans are realistic, and outcomes include measures that matter to people living with cancer.
18) Are animal studies allowed under this award?
No. This award does not support animal studies.
19) Can preclinical development be included as part of the funded work?
No. Any preclinical development, including animal efficacy or toxicology work needed to justify human testing, must be completed before the award start date.
20) What kind of research team is best positioned for this award?
This mechanism is best suited to teams that have already generated the necessary preclinical or translational evidence and are ready to execute a human clinical trial promptly.
21) What is the stated eligibility for applicants?
Eligibility is listed as unrestricted.
22) How many awards does the program expect to make?
The program anticipates making about 10 awards.
23) What is the maximum award amount (award ceiling)?
The award ceiling is not specified in the provided listing. Applicants would need to consult the full announcement or agency guidance for budget limits and any cost-related constraints.
24) What is the overall goal of the CTA mechanism?
The overall goal is to move cancer research quickly into the clinic by funding clinical trials that could meaningfully improve cancer treatment or management and that have the potential to influence clinical practice, patient outcomes, or standards of care if successful.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Previous opportunity: DoW Spinal Cord Injury, Clinical Trial Award
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT942526PRCRPCTA
Applicants also applied for:
Applicants who have applied for this opportunity (HT942526PRCRPCTA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoW Peer Reviewed Cancer, Idea Award Apply for HT942526PRCRPIA Funding Number: HT942526PRCRPIA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW, Peer Reviewed Cancer, Impact Award Apply for HT942526PRCRPIPA Funding Number: HT942526PRCRPIPA Agency: Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Ecological Parameters in the Forested Wetlands of Southern Florida Apply for W9126G262SOI9383 Funding Number: W9126G262SOI9383 Agency: Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $3,177,238 |
| NIJ FY25 Research and Evaluation of Policing Practices Apply for O NIJ 2025 172603 Funding Number: O NIJ 2025 172603 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $5,000,000 |
| NIJ FY25 Research and Evaluation on Youth Justice Topics Apply for O NIJ 2025 172607 Funding Number: O NIJ 2025 172607 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $4,000,000 |
| Willow Creek Reservoir Water Quality Research and Evaluation Studies Apply for W81EWF 26 SOI 0003 Funding Number: W81EWF 26 SOI 0003 Agency: Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $100,000 |
| Standards Coordination Office Curricula Development Cooperative Agreement Program Apply for 2026 NIST SCOCD 01 Funding Number: 2026 NIST SCOCD 01 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Cooperative Agreement for affiliated Partner with the Hawaii-Pacific Island Cooperative Ecosystem Studies Unit Apply for G26AS00117 Funding Number: G26AS00117 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $85,500 |
| Cooperative Agreement for affiliated Partner with the Desert Southwest Cooperative Ecosystem Studies Unit Apply for G26AS00116 Funding Number: G26AS00116 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $499,550 |
| Cooperative Agreement for affiliated Partner with the Gulf Coast Cooperative Ecosystem Studies Unit Apply for G26AS00114 Funding Number: G26AS00114 Agency: Geological Survey Category: Science and Technology and other Research and Development Funding Amount: $400,000 |
| NIJ FY25 Research and Evaluation of Emerging Technology Implementation and Impact for Law Enforcement Purposes Apply for O NIJ 2025 172616 Funding Number: O NIJ 2025 172616 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $3,000,000 |
| NIJ FY25 Research and Evaluation of Artificial Intelligence for Criminal Justice Purposes Apply for O NIJ 2025 172615 Funding Number: O NIJ 2025 172615 Agency: National Institute of Justice Category: Science and Technology and other Research and Development Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HT942526PRCRPCTA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.